Alkermes to Report Second Quarter Financial Results on July 27, 2022

<br /> Alkermes to Report Second Quarter Financial Results on July 27, 2022<br />

PR Newswire

DUBLIN

,

July 20, 2022

/PRNewswire/ —

Alkermes plc

(Nasdaq: ALKS) will host a conference call and webcast presentation at

8:00 a.m. ET

(

1:00 p.m. BST

) on

Wednesday, July 27, 2022

to discuss the company’s second quarter financial results. Management will also provide an update on the company.

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes’ website at

www.alkermes.com

. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. A replay of the webcast will be available approximately two hours after the completion of the event and may be accessed by visiting Alkermes’ website.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham,

Massachusetts

; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at

www.alkermes.com

.

Alkermes Contact:

Alex Braun

Investor Relations

+1 781 296 8493